


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-10.54%
+6.99%
+9.81%
-25.94%
+0.58%
ATHA
Athira Pharma
$6.97
ATHA Price Performance
$4.42 (+57.69%)
$4.14 (+68.36%)
$0.37 (+1783.78%)
$0.57 (+1122.81%)
ATHA has Medium risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

ATHA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
ATHA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ATHA Street Sentiment is extremely bullish and have negative views on the near-term outlook
What is ATHA current stock price?
What are ATHA stock strengths?
What is ATHA Risk Level?
What is ATHA market cap and volume?
What is ATHA current Stock IQ?
Should I buy ATHA stock right now?
Is ATHA a Strong Buy right now?
What does a 'Strong Buy' rating mean for ATHA?
What does a 'Strong Sell' rating mean for ATHA?
What factors influence ATHA's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-10.54%
+6.99%
+9.81%
-25.94%
+0.58%
ATHA
Athira Pharma
Current Price
$6.97

ATHA Price Performance
$4.42 (+57.69%)
$4.14 (+68.36%)
$0.37 (+1783.78%)
$0.57 (+1122.81%)
ATHA Analysts Opinion
ATHA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
ATHA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ATHA Street Sentiment is extremely bullish and have negative views on the near-term outlook
ATHA has Medium risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

ATHA Stock IQ
ATHA Latest Analysis
Why Is Athira Pharma Stock Spiking After Breast Cancer Asset Acquisition?. ATHA) stock is trading higher on Thursday with a session volume of 57.29 million compared to the average volume of 30.94 thousand as per .Athira Pharma on Thursday agreed to acquire the rights for the development and commercialization of lasofoxifene a clinical asset in a potentially registrational Phase 3 trial.The ongoing Phase 3 ELAINE-3 clinical trial is greater than 50% enrolled with data expected in mid-2027.Athira
Thu Dec 18, 2025
Athira Pharma Shares Jump 70% On Phase 3 Asset Acquisition Deal . (RTTNews) - Athira Pharma Inc. (ATHA) shares surged 69.53 percent gaining $2.88 to trade at $7.01 on Thursday after the clinical-stage biopharmaceutical company announced an agreement to acquire global development and commercialization rights to lasofoxifene a Phase 3 ready a
Thu Dec 18, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ATHA Stock trends
ATHA Stock performance
ATHA Stock analysis
ATHA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.